Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03982004
Title Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

breast cancer

Therapies

Imiquimod + Pembrolizumab + Sargramostim

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.